WallStreetZenWallStreetZen

NYSE: CRH
Crh Public Ltd Co Stock

Overview
ForecastEarningsRevenueDividendOwnership
$82.71-2.04 (-2.41%)
Updated Apr 21, 2025
CRH Price
$82.71
Fair Value Price
N/A
Market Cap
$55.95B
52 Week Low
$71.18
52 Week High
$110.97
P/E
16.35x
P/B
2.59x
P/S
1.78x
PEG
1.2x
Dividend Yield
0.45%
Revenue
$35.57B
Earnings
$3.49B
Gross Margin
35.7%
Operating Margin
14.59%
Profit Margin
9.8%
Debt to Equity
1.29
Operating Cash Flow
$5B
Beta
1.17
Next Earnings
Apr 25, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CRH Overview

CRH plc is the parent of companies that manufacture building materials and operate builders' supply and 'Do-It-Yourself' stores. Offerings include cement, aggregates, ready-mixed concrete, asphalt/bitumen, and agricultural and/or chemical lime. Resulting from the 1970 merger of Cement Limited and Roadstone Limited, CRH plc is headquartered in Dublin, Ireland.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CRH's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Building Material

Industry Rating
C
CRH
Ranked#9 of 16

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
United States Lime & Minerals (USLM)
$86.77B
Tecnoglass (TGLS)
$66.33C
Smith Midland (SMID)
$29.44C
View Top Building Material Stocks

Be the first to know about important CRH news, forecast changes, insider trades & much more!

CRH News

Overview

Due Diligence Score

–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRH ($82.71) is trading above its intrinsic value of $51.32, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRH is good value based on its earnings relative to its share price (16.35x), compared to the US market average (27.14x)
P/E vs Market Valuation
CRH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CRH due diligence checks available for Premium users.

Valuation

CRH price to earnings (PE)

For valuing profitable companies with steady earnings

Company
16.35x
Industry
25.83x
Market
27.14x
CRH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CRH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.59x
Industry
2.61x
CRH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRH price to earnings growth (PEG)

For valuing profitable companies with growth potential

CRH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CRH's financial health

Profit margin

Revenue
$8.9B
Net Income
$703.0M
Profit Margin
7.9%
CRH's Earnings (EBIT) of $5.19B... subscribe to Premium to read more.
Interest Coverage Financials
CRH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$50.6B
Liabilities
$27.8B
Debt to equity
1.29
CRH's short-term assets ($14.08B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRH's long-term liabilities ($17.47B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CRH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.7B
Investing
-$1.9B
Financing
-$42.0M
CRH's operating cash flow ($4.99B)... subscribe to Premium to read more.
Debt Coverage Financials

CRH vs Building Material Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CRHC$55.95B-2.41%16.35x2.59x
VMCC$30.94B-3.21%33.99x3.81x
MLMD$29.58B-1.86%14.93x3.13x
JHXC$9.37B-3.02%21.58x4.46x
CXC$7.67B-2.04%125.95x0.65x
View Top Building Material Stocks

Crh Public Co Stock FAQ

What is Crh Public Co's quote symbol?

(NYSE: CRH) Crh Public Co trades on the NYSE under the ticker symbol CRH. Crh Public Co stock quotes can also be displayed as NYSE: CRH.

If you're new to stock investing, here's how to buy Crh Public Co stock.

What is the 52 week high and low for Crh Public Co (NYSE: CRH)?

(NYSE: CRH) Crh Public Co's 52-week high was $110.97, and its 52-week low was $71.18. It is currently -25.47% from its 52-week high and 16.21% from its 52-week low.

How much is Crh Public Co stock worth today?

(NYSE: CRH) Crh Public Co currently has 676,475,037 outstanding shares. With Crh Public Co stock trading at $82.71 per share, the total value of Crh Public Co stock (market capitalization) is $55.95B.

Crh Public Co stock was originally listed at a price of $11.55 in Dec 31, 1997. If you had invested in Crh Public Co stock at $11.55, your return over the last 27 years would have been 616.1%, for an annualized return of 7.56% (not including any dividends or dividend reinvestments).

How much is Crh Public Co's stock price per share?

(NYSE: CRH) Crh Public Co stock price per share is $82.71 today (as of Apr 21, 2025).

What is Crh Public Co's Market Cap?

(NYSE: CRH) Crh Public Co's market cap is $55.95B, as of Apr 22, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Crh Public Co's market cap is calculated by multiplying CRH's current stock price of $82.71 by CRH's total outstanding shares of 676,475,037.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.